Physician profile
Michael Erickson
NPI 1336529312
$18,127.21
in general payments reported to CMS, 2019-2025
10 companies · $9,849 in 2025
The $9,849 reported for 2025 was more than what 96% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.91 · 2022: $5,727 · 2023: $1,056 · 2024: $1,460 · 2025: $9,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,500 · Travel and Lodging: $1,526 · Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,500.00 |
| Travel and Lodging | $1,525.83 |
| Food and Beverage | $1,338.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,515.53 | 2022-2025 | Davinci Xi |
| Zimmer Biomet Holdings, INC. | $1,047.03 | 2022-2024 | Ribfix Blu Advantage |
| Boston Scientific Corporation | $240.39 | 2025 | General - Therapies |
| Avita Medical Americas, LLC | $203.92 | 2024 | |
| Masimo Corporation | $28.20 | 2023 | Sedline, Set and Rainbow Set |
| Kerecis Limited | $27.39 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Hemosonics LLC | $19.76 | 2021 | |
| Medtronic, INC. | $16.15 | 2021 | |
| Amgen INC. | $14.85 | 2022 | |
| Biotissue Holdings INC. | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.